technology

Colossal Biosciences seeks to raise new capital at a valuation between $20B and $30B

20 Temmuz 2026TechCrunch

Colossal Biosciences, a startup focused on de-extinction, is reportedly in discussions to raise new capital at a valuation between $20 billion and $30 billion. This represents a significant increase, potentially doubling or tripling its previous valuation.
The company's ambitious goals in the field of genetic engineering and species revival continue to attract investor interest.
Colossal Biosciences is at the forefront of a burgeoning industry that seeks to bring back extinct species through advanced genetic techniques. The discussions around new capital raise highlight the growing interest in biotechnology and conservation efforts, especially as environmental concerns escalate globally.
The substantial valuation range indicates strong investor confidence in Colossal Biosciences' vision and technology. As the de-extinction sector gains traction, the financial backing could enable the company to accelerate its research and development efforts.

NewsAI özeti

This article is based on reports and may not reflect the latest developments in Colossal Biosciences' funding efforts.